Fresh Recalls

FDAClass III · Medical device · Recall Z-2880-2026 · Recalled August 12, 2026

Syva Emit Disopyramide Assay Enzyme Immunoassay recall — Siemens Healthcare Diagnostics, Inc.

Agency report date: August 12, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Syva Emit Disopyramide Assay Enzyme Immunoassay
Company / brand
Siemens Healthcare Diagnostics
Lot / serial / date codes
UDI-DI 00842768001406 Lot U1
Distribution
Worldwide - US Nationwide distribution in the states of CA and VA. The country of Japan.
Agency product description and boundaries

Syva Emit Disopyramide Assay Enzyme Immunoassay, Lidocaine SMN 10445370 Catalog No 6N319UL

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Out-of-specification sodium azide concentration in Syva Emit Disopyramide Enzyme Immunoassay Calibrator Lot U1. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is low, as exposure is limited by small volumes and a 0.2% post-reconstitution sodium azide concentration, with the worst outcome being mild skin or eye irritation and no serious harm anticipated.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class III: not likely to cause adverse health consequences.

Affected product: Syva Emit Disopyramide Assay Enzyme Immunoassay

3. Open the official notice or contact

Official recall ID
Z-2880-2026
Brand
Siemens Healthcare Diagnostics
Classification
Class III
Units affected
8 US; 44 OUS
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Newark, DE, United States
Firm address
500 Gbc Dr, 19702-2466

Identifying details (verbatim from the notice)

Product codes / lots
UDI-DI 00842768001406 Lot U1
Distribution
Worldwide - US Nationwide distribution in the states of CA and VA. The country of Japan.
Firm notified the public via
Letter
FDA event ID
99379
Recall initiated
June 26, 2026
FDA classified
August 4, 2026
FDA report date
August 12, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page